2022 American Transplant Congress
Variation in Adult Living Donor Liver Transplantation in the United States: Identifying Opportunities for Increased Utilization
*Purpose: To assess barriers to living donor liver transplant (LDLT) access in light of convincing evidence of survival benefits for patients with end-stage liver disease.*Methods:…2022 American Transplant Congress
Center-Level Variability in DDLT Rate Before and After the Implementation of MMaT/250 Score
Johns Hopkins Medical Institutions, Baltimore, MD
*Purpose: In 02/2020, OPTN replaced DSA/regional boundaries with acuity circles and substituted exception scores for individual patients to median-MELD-at-transplant within 250 nautical miles of a…2022 American Transplant Congress
The Paradox of Lifestyle – Related Liver Disease: ASH and NASH
*Purpose: In the last decade, the burden of lifestyle-related chronic disease has been on the rise and is considered a growing serious public health concern.…2022 American Transplant Congress
Oxygen Saturation During Donor Warm Ischemia Time and Outcome of Donation After Circulatory Death (DCD) Liver Transplantation: A Review of 1207 Cases
Loyola Univ Chicago, Maywood, IL
*Purpose: Donation after circulatory death (DCD) liver transplantation (LT) is associated with increased risk of graft failure due to the donor warm ischemia time (DWIT)…2022 American Transplant Congress
Variation in Immunosuppressive Regimen in Children Receiving Liver Transplants: An Analysis of the UNOS Database
*Purpose: Optimizing immunosuppression (IS) was identified as a priority for pediatric liver transplant (LT) families and providers in the Starzl Network, a multi-center learning health…2022 American Transplant Congress
Use of Monoclonal Antibodies for Treatment of Solid Organ Transplant Recipients with COVID-19: A Single Center Experience
*Purpose: The risk of severe COVID-19 requiring hospitalization and death is higher in solid organ transplant recipients (SOTr). There remains limited data on the use…2022 American Transplant Congress
Defining the Longitudinal Dynamics of Immune Cells in Blood in the First Year After Pediatric Liver Transplantation (pLTx)
*Purpose: In the European multicentre “ChilSFree” study we aimed for a deep characterisation of the longitudinal immune dynamics during the first year after pLTx.*Methods: Absolute…2022 American Transplant Congress
Impact of Sarcopenia Using L3 and Thigh Skeletal Muscle Index on Clinical Outcomes in Liver Transplantation Recipient
Department of Surgery, Samsung Medical Cener, Seoul, Korea, Republic of
*Purpose: Sarcopenia is defined as loss of muscle mass and function. It has been reported as a significant risk factor for outcome after Liver transplantation…2022 American Transplant Congress
Acute Cellular Rejection in Liver Transplant Recipients Following Vaccination Against Covid-19
*Purpose: The coronavirus disease 2019 (COVID-19) global pandemic has seen the development of effective vaccines in record time. We report a series of five liver…2022 American Transplant Congress
Evaluating the Performance and External Validity of Machine Learning-Based Prediction Models in Liver Transplantation: An International Study
*Purpose: National liver transplant (LT) registries are curated in many countries. We compared data from three national registries and developed machine learning algorithm (MLA)-based models…
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 180
- Next Page »